相关实验视频
Updated: May 20, 2025

08:24
A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation
Published on: May 9, 2012
20.9K
在肌肉特异性激酶骨质疏松症的诱导和维持治疗中使用efgartigimod
Yufan Zhou1,2,3, Qian Zhou4, Yaoxian Yue5
1Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Therapeutic advances in neurological disorders
|March 27, 2025
概括
与免疫疗法相结合的efgartigimod对MuSK-MG患者来说是有前途的,显著改善日常活动并减少症状. 这种组合疗法为这种罕见的自身免疫性疾病提供了潜在的新治疗途径.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在MuSK-MG患者中,efgartigimod的有效性在临床试验中仍然未被证明.
- 从案例报告和观察性研究中存在有限的证据.
研究的目的:
- 为了评估efgartigimod与塔克罗利斯或B细胞耗尽剂相结合的MuSK-MG.
- 评估作为维持疗法的疗效和安全性.
主要方法:
- 对14名接受efgartigimod治疗的MuSK-MG患者进行了回顾性研究.
- 收集了关于ADL得分,定量肌痛性骨髓炎得分和最小症状表达时间 (MSE) 的数据.
- 记录了同时使用免疫疗法和不良事件的记录.
主要成果:
- 从基线 (10.1) 到第4周 (2.2) 的MG-ADL得分显著降低 (p=0.001).
- 92.9%的患者在8周以上的时间内保持了≥2点的减肥率.
- 到MSE的中位时间为4周; 71.4%的患者在第12周实现了MSE.
- 在联合免疫疗法中观察到较低的普得尼松剂量.
结论:
- 结合维护免疫治疗的efgartigimod诱导有益于MuSK-MG患者.
- 这种组合疗法可能是一种有效的治疗策略.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K
Myasthenia Gravis: Diagnostic Tests
581
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
581
Disorders of the Skeletal Muscle
840
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
840
Antiepileptic Drugs: Potassium Channel Activators
138
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
138
Skeletal Muscle Relaxants: Therapeutic Uses
445
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
445
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
588
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
588

